ArticleFrontiers in immunology2025
Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We investigated the diagnostic challenges of TAFRO syndrome and idiopathic multicentric Castleman disease (iMCD), focusing on the usefulness of anterior mediastinal lesions for distinguishing the disease subtypes. A comparative analysis using computed tomography (CT) imaging was performed for three patient groups: TAFRO without iMCD/iMCD-TAFRO (n=13), iMCD-idiopathic plasmacytic lymphadenopathy (IPL)- not otherwise specified (NOS) (n=16), and IgG4-related disease (IgG4-RD) (n=59). Lesions were categorized into increased fat density, micronodular opacity, and mass. The lesions' CT attenuation values were compared, and receiver operating characteristic (ROC) curve analyses assessed their diagnostic relevance. Anterior mediastinal lesions were most frequent in the TAFRO without iMCD/iMCD-TAFRO group (85%) compared to the iMCD-IPL/NOS group (31%) and IgG4-RD group (6.8%). Distinct patterns such as increased fat density were predominantly observed in the TAFRO without iMCD/iMCD-TAFRO group. The CT values showed significant intergroup differences, with ROC analyses confirming high diagnostic accuracy for distinguishing the TAFRO without iMCD/iMCD-TAFRO group from the other groups. Post-treatment, all patients with TAFRO without iMCD/iMCD-TAFRO showed improvement in CT readings, whereas only half of the patients with iMCD-NOS group showed changes. These findings emphasize the importance of CT-detected anterior mediastinal lesions in the diagnosis of TAFRO without iMCD/iMCD-TAFRO and warrant further research to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.